PubMed:29375047 / 1110-1420 JSONTXT

Annnotations TAB JSON ListView MergeView

GoldHamster

Id Subject Object Predicate Lexical cue
T216 59-68 PR:000025876 denotes ovalbumin
T217 59-68 E2RVI8 denotes ovalbumin
T218 59-68 P19104 denotes ovalbumin
T219 59-68 P01012 denotes ovalbumin
T222 59-68 O73860 denotes ovalbumin
T223 59-68 Q6V115 denotes ovalbumin
T220 59-68 D010047 denotes ovalbumin
T221 59-68 D010047 denotes ovalbumin
T226 152-161 358263 denotes tadalafil
T224 152-161 D000068581 denotes tadalafil
T225 152-161 CHEBI:71940 denotes tadalafil
T227 152-161 D000068581 denotes tadalafil
T228 165-176 1091836 denotes roflumilast
T229 165-176 CHEBI:47657 denotes roflumilast
T230 165-176 C424423 denotes roflumilast
T231 165-176 C424423 denotes roflumilast
T233 262-275 3264 denotes dexamethasone
T232 262-275 D003907 denotes dexamethasone
T234 262-275 CHEBI:41879 denotes dexamethasone
T235 262-275 D003907 denotes dexamethasone

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T6 0-203 DRI_Background denotes Control group was non-sensitized, while other animals were ovalbumin-sensitized over two weeks and thereafter treated intraperitoneally for 7 days with tadalafil or roflumilast (daily dose 1.0 mg/kg b.w.

Inflammaging

Id Subject Object Predicate Lexical cue
T7 0-310 Sentence denotes Control group was non-sensitized, while other animals were ovalbumin-sensitized over two weeks and thereafter treated intraperitoneally for 7 days with tadalafil or roflumilast (daily dose 1.0 mg/kg b.w. each), with their combination (0.5 mg/kg b.w. each), with dexamethasone (1.0 mg/kg b.w.), or with vehicle.
T7 0-310 Sentence denotes Control group was non-sensitized, while other animals were ovalbumin-sensitized over two weeks and thereafter treated intraperitoneally for 7 days with tadalafil or roflumilast (daily dose 1.0 mg/kg b.w. each), with their combination (0.5 mg/kg b.w. each), with dexamethasone (1.0 mg/kg b.w.), or with vehicle.